2013 American Transplant Congress
Quantifying Improvement in Donor Travel Safety: Utilization of Centralized Procurement Facilities and outside Surgeon Organ Procurement
Department of Surgery, Division of Transplantation, University of Michigan, Ann Arbor, MI
Intro: Air based organ procurement travel has been noted to be the dangerous. As a 5-year follow-up to the Michigan Donor Travel Forum, we sought…2013 American Transplant Congress
Adverse Events of Over-Immunosuppression Are Dependent on Tofacitinib Exposure in Kidney Transplant (KT) Patients
Background: In a prior Phase 2b study in de novo KT pts, a CNI-free tofacitinib fixed-dose regimen achieved comparable rate of biopsy-proven acute rejection (BPAR),…2013 American Transplant Congress
Mycophenolic Acid (MPA) Dosing: Effect on Efficacy to 4 Years after Kidney Transplantation in the Mycophenolic Acid Observational Renal Transplant (MORE) Study
Maintaining adequate MPA dose may be important to optimize efficacy after kidney transplantation, but prospective long-term data are rare.Methods. MORE was a prospective, observational study…2013 American Transplant Congress
How To Handle a Missed or Delayed Dose Intake? A Pharmacokinetic Study of Cyclosporine and Tacrolimus in Renal Transplant Patients
BACKGROUND and OBJECTIVES: Despite the efforts made to optimize adherence, every transplant patient will, at least occasionally, miss doses or take them outside the prescribed…2013 American Transplant Congress
Does African American (AA) Ethnicity Affect Kidney Transplant Outcomes at Four Years? An Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Study
Prospective data regarding kidney transplant outcomes in AA kidney transplant patients using modern immunosuppressive regimens are limited.Methods: MORE was a 4-year, prospective, observational study at…2013 American Transplant Congress
Outcomes of Transplantation for Uncontrolled HCC and Rescue with Marginal Quality Grafts
Surgery, University of Pennsylvania, Philadelphia, PA
Introduction We examined the survival of patients transplanted for progressive hepatocellular cancer (HCC) not controlled with locoregional therapy (LRT) and the impact of the strategy…2013 American Transplant Congress
Economic Impact of Pulsatile Hyothermic Perfusion in an Expanded Criteria Donor Transplant Program. Analysis of the First Year Implementation
INTRODUCTIONKidney transplant (KT) from expanded criteria donors (ECD) have a higher rate of delayed graft function (DGF) that increases postoperative costs because of prolonged hospital…2013 American Transplant Congress
Characterization of the Immune Response after Intravenous Infusion of Mesenchymal Stem Cells
Experimental animal models show beneficial effects of administration of mesenchymal stem cells (MSC) on ischemia-reperfusion injury and survival of organ transplants. The immunomodulatory responses that…2013 American Transplant Congress
Can the Risk of Cancer Transmission from Organ Donors Be Eliminated?
Donor origin cancer (DOC) in transplant recipients may be transmitted with the graft (donor-transmitted cancer [DTC]) or develop subsequently from the graft (donor-derived cancer [DDC]).…2013 American Transplant Congress
Long-Term Outcomes of Liver Transplant Patients with HIV-1 Infection: a 14-Year Single-Center Clinical Experience
Background: Liver transplantation (LT) for patients with Human immunodeficiency virus type-1 (HIV-1) infection has been associated with poor outcome. However, after the introduction of the…
American Transplant Congress abstracts